Ratan Tata invests in medtech startup Axio
The company plans to use the funds for expansion to new markets, while continuing to work on high-impact medical products.
Axio Biosolutions has raised $7.4 million in a Series B funding round led by Ratan Tata`s RNT Capital along with existing investors Accel Partners and IDG Ventures India, a company statement said here on Friday.
The company plans to use the funds for expansion to new markets, while continuing to work on high-impact medical products.
Masterkey Holdings was the advisor for the transaction.
Axio had earlier launched an emergency haemostat for trauma care.
Headquartered in Boston, Axio Biosolutions has its corporate office in Bengaluru and GMP certified manufacturing facility in Gujarat.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
Power of Compounding: How many years it will take to reach Rs 2 crore corpus if your monthly SIP is Rs 3,000, Rs 4,000, or Rs 5,000
Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment
12:17 PM IST